HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: Results from the Sentinel Sites study

British Journal of Cancer

Volumn 105, Issue 7, 2011, Pages 983-988

  Kelly, R S ^a   Patnick, J ^b   Kitchener, H C ^c   Moss, S M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

cervical cytology; human papillomavirus; screening; triage

Indexed keywords

ADULT; ARTICLE; COLPOSCOPY; CYTOLOGY; DYSKARYOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PATIENT REFERRAL; PREDICTIVE VALUE; PRIORITY JOURNAL; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CYTOLOGICAL TECHNIQUES; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TRIAGE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 80053243490     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.326     Document Type: Article

References (21)

1. Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J (2004) Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 96(4): 280-293 (Pubitemid 38256273)
2. Arbyn M, Martin-Hirsch P, Buntinx F, Van RM, Paraskevaidis E, Dillner J (2009) Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med 13(4): 648-659
3. Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J (2005) Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 99(3 Suppl 1): S7-S11 (Pubitemid 41774340)
4. Bergeron C, Jeannel D, Poveda J, Cassonnet P, Orth G (2000) Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol 95(6 Pt 1): 821-827
5. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R, Brooks C, Desai M, Gie C, Ho L, Jacobs I, Pickles C, Sasieni P (2003) Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 362: 1871-1876 (Pubitemid 37518501)
6. Guyot A, Karim S, Kyi MS, Fox J (2003) Evaluation of adjunctive HPV testing by hybrid capture II in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy. BMC Infect Dis 3: 23
7. Howell-Jones R, Bailey A, Beddows S, Sargent A, de SN, Wilson G, Anton J, Nichols T, Soldan K, Kitchener H (2010) Multi-site study of HPV type-specific prevalence in women with cervical cancer, intra-epithelial neoplasia and normal cytology, in England. Br J Cancer 103(2): 209-216
8. Kitchener HC, Almonte M, Wheeler P, Desai M, Gilham C, Bailey A, Sargent A, Peto J (2006) HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer 95(1): 56-61 (Pubitemid 43980554)
9. Legood R, Gray A, Wolstenholme J, Moss S (2006) Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies. BMJ 332(7533): 79-85
10. Moss S, Gray A, Legood R, Vessey M, Patnick J, Kitchener H (2006) Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ 332(7533): 83-85 (Pubitemid 43099248)
11. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L (2006) Chapter 1: HPV in the etiology of human cancer. Vaccine 24(Suppl 3): S3/1-10
12. NHS (2009) Office for national statistics; cancer statistics registrations. Series MBI No.37, http://www.statistics.gov.uk/statbase/Product. asp?vlnk=8843
13. Peto J, Gilham C, Fletcher O, Matthews FE (2004) The cervical cancer epidemic that screening has prevented in the UK. Lancet 364(9430): 249-256 (Pubitemid 38942814)
14. Rebello G, Hallam N, Smart G, Farquharson D, McCafferty J (2001) Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study. BMJ 322(7291): 893-894 (Pubitemid 32324310)
15. Sargent A, Bailey A, Turner A, Alimonte M, Gilham C, Baysson H, Peto J, Roberts C, Thomson C, Desai M, Mather J, Kitchener H (2010) Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus; data from the ARTISTIC trial. J Clin Microbiol 48(2): 554-558
16. Sasieni PD, Cuzick J, Lynch-Farmery E (1996) Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 73(8): 1001-1005 (Pubitemid 26116757)
17. Szarewski A, Ambroisine L, Cadman L, Austin J, Ho L, Terry G, Liddle S, Dina R, McCarthy J, Buckley H, Bergeron C, Soutter P, Lyons D, Cuzick J (2008) Comparison of predictors for high-grade cervical intraepithelial neoplasia in woman with abnormal smears. Cancer Epidemiol Biomar-kers Prev 17(11): 3033-3042
18. TOMBOLA Group (2009a) Biopsy and selective recall compared with immediate large loop excision in management of women with low grade cervical cytology referred for colposcopy: mulitcentre randomised controlled trial. BMJ 339: b2549
19. TOMBOLA Group (2009b) Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ 339: b2546
20. TOMBOLA Group (2009c) Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ 339: b2549
21. Waterhouse J, Muir C, Correa P, Powel J eds. (1976) Cancer incidence in five continents. In International Agency for Research on Cancer, World Health Organisation, Vol. III, IARC Scientific Publication No 15: Lyon